June 18th 2021, 2:11pm
The Biden administration has promised to invest billions in antiviral medicine development; certain hospitals associated with Black patients' COVID-19 mortality rates; increased rates of medicaid enrollment.
June 18th 2021, 12:15pm
The Medicare Payment Advisory Commission (MedPAC) suggested several changes to Medicare Advantage (MA) plan benchmark calculations, with the intent to generate yield savings for Medicare, and urged CMS to streamline alternative payment model (APMs) where it can.
June 17th 2021, 4:23pm
In a 7 to 2 decision, the Supreme Court ruled Thursday that the Affordable Care Act (ACA) will stand, as plaintiffs seeking to declare the law unconstitutional did not have standing.
June 16th 2021, 1:00pm
Mean in-network commercial allowed amounts and charges per anesthesia conversion factor are 314% and 659% of traditional Medicare rates, respectively. Medicare Advantage payments align with traditional Medicare prices.
June 15th 2021, 10:00pm
On this episode of Managed Care Cast, we speak with the author of the annual PwC Behind the Numbers report, which looks ahead at medical cost trends in the United States.
June 14th 2021, 4:00pm
The No Surprises Act represents a rare bipartisan moment for Congress and a long-needed safeguard for patients that will reorient relationships among payers and providers.
June 14th 2021, 1:00pm
Hospital performance measures, such as prices and costs, are associated with hospital-insurer contract types.
June 11th 2021, 5:00pm
A new study from Milliman investigated the potential financial impact if H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act, was fully implemented.
June 10th 2021, 2:05pm
United States to buy and donate 500 million COVID-19 vaccine doses to the world; an FDA advisor resigns over a controversial Alzheimer drug approval; Nevada becomes the second state to offer state-managed health insurance plans.
June 9th 2021, 3:47pm
An initiative launched with the intent to deliver equitable cancer care improved the enrollment rates of Black participants in cancer clinical trials by focusing on community outreach and engagement.
